Valuation: Tissue Therapies Limited

Market Cap 17.59M 12.37M 11.1M 10.25M 9.3M 17.38M 1.18B 123M 48.82M 616M 46.44M 45.45M 1.95B P/E 2024
-5.88x
P/E 2025 -6.17x
Enterprise Value 15.11M 10.63M 9.54M 8.81M 7.99M 14.93M 1.01B 106M 41.95M 529M 39.9M 39.05M 1.68B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
70.64%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 2025-06-02
Director of Finance/CFO - 2024-09-11
Director TitleAgeSince
Director/Board Member 42 2021-10-31
Director/Board Member - 2021-10-31
Director/Board Member - 2025-09-18
Change 5-day change 1-year change 3-year change Capi.($)
+4.53%-3.91%+51.98%+196.85% 157B
+1.21%-4.24%+60.46%+95.87% 93.57B
+2.11%-2.02%-18.68%+158.93% 42.26B
+4.32%+0.58%+22.04%+140.98% 41.77B
+1.03%-.--%-.--%-.--% 31.84B
+5.25%-0.30%+18.31%+28.97% 20.24B
+5.16%+0.20%+54.55% - 17.06B
+2.45%-3.30%-10.85%+161.25% 16.13B
-5.05%+0.80%-47.78%-43.67% 15.85B
Average +2.33%-3.79%+14.45%+92.40% 48.42B
Weighted average by Cap. +2.94%-3.43%+32.86%+131.32%

Financials

2024 2025
Net sales - -
Net income -1.23M -864K -776K -716K -649K -1.21M -82.08M -8.59M -3.41M -43.02M -3.24M -3.17M -136M -1.59M -1.12M -1M -925K -838K -1.57M -106M -11.08M -4.4M -55.55M -4.19M -4.1M -176M
Net Debt -2.04M -1.43M -1.29M -1.19M -1.08M -2.01M -136M -14.25M -5.66M -71.42M -5.38M -5.27M -226M -2.48M -1.74M -1.56M -1.44M -1.31M -2.45M -165M -17.31M -6.88M -86.75M -6.54M -6.4M -275M
Logo Tissue Therapies Limited
Invert Graphite Ltd, formerly Dominion Minerals Limited, is an Australia-based high-graphite company. The Company has executed binding agreements to conditionally acquire a 100% interest in the Morogoro graphite project in Tanzania and the White Hill Licenses in South Australia.
Employees
-